Dissemination and implementation of research evidence and innovation to clinical practice; and
Interventions at community and/or clinical practices to promote health equity.
Later stages of Translational Research (T3/T4) are the target for this year’s program. One-page letters of intent (LOI) are due Nov. 15 at 11:59 p.m. via InfoReady.
Applicants will submit a letter of intent to clearly enunciate the proposed activities that address one or more of these goals with a sustainable design for future application to community health. Applicants submitting a successful LOI will be invited to submit a full proposal.
A minimum of two, and up to six grants, will be awarded with budgets of up to $50,000 each in direct costs. All research activities must be completed by June 30, 2025.
The ideal letter of intent will address a later stage of clinical research (T3/T4) of community health with an articulated, quantitative outcome result leading to a change in health using translational research approaches. Examples that will be more favorably reviewed are projects that:
Build teams across biological and behavioral methodology and clinical health science;
Articulate the innovation for the applicant and/or the co-investigator(s);
Use community engagement principles to address equity in deployment of the outcomes;
Show incremental impact, if any, of a novel strategy to improve health in special populations (e.g. children, minorities, handicapped, elderly, vulnerable, etc.).